Akums unveils Vildagliptin SR and Metformin SR tablets EP News Bureau Aug 25, 2023 Vildagliptin SR and Metformin SR tablets are available in four strengths: 50 mg/500 mg, 50 mg/1000 mg, 100 mg/500 mg, and 100…
Dr Reddy’s Laboratories launch Saxagliptin and Metformin Hydrochloride ER tablets in US EP News Bureau Aug 10, 2023 Saxagliptin and metformin hydrochloride ER tablets are indicated as an adjunct to diet and exercise to improve glycemic control in…
Glenmark launches FDC of Teneligliptin + Pioglitazone + Metformin EP News Bureau Dec 21, 2022 The triple FDC will help improve glycemic control among adults with High HbA1c and high insulin resistance, those whose diabetes…
US study finds diabetes drug metformin may reduce COVID death risk by half Press Trust of India Aug 19, 2022 The widely available diabetes drug metformin may reduce the risk of emergency room visits, hospitalisation, and death from…
NPPA fixes retail prices of Vildagliptin 50 mg + Metformin Hydrochloride 500 mg and 1000 mg SR… Usha Sharma Feb 16, 2021 It has decided to fix the retail price as per the Price To Retailer (PTR) based on Form-V data submitted by the companies for whom…
Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin EP News Bureau Nov 24, 2020 The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80
Aarti Drugs to expand metformin capacity to 3000 TPM EP News Bureau Oct 31, 2020 The company will start the Phase I expansion project to 2000 TPM in FY20-21
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical Press Trust of India Jun 10, 2020 The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA
Marksons Pharma voluntarily recalls a batch of Metformin XR tablets EP News Bureau Jun 8, 2020 It is due to the detection of NDMA
Accurate, sensitive mass techniques required to identify specific peak of certain nitrosamines Viveka Roychowdhury May 29, 2020 Continuing its investigation into the presence of potential carcinogenic materials in various medicines, on May 28, the US FDA…